Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival.

• Published in: Acta Oncologica
• Main Authors: Oskarsdottir, G N, Halldorsson, H, Sigurdsson, M I, Fridriksson, B M, Baldvinsson, K, Orrason, A W, Jonsson, S, Planck, M, Gudbjartsson, T
• Other Authors: 1 Landspitali Univ Hosp, Dept Cardiothorac Surg, Reykjavik, Iceland Show the Organization-Enhanced name(s) 2 Skane Univ Hosp, Dept Pulmonol, Lund, Sweden Show the Organization-Enhanced name(s) 3 Landspitali Univ Hosp, Dept Pulmonol, Reykjavik, Iceland Show the Organization-Enhanced name(s) 4 Univ Iceland, Fac Med, Reykjavik, Iceland
• Format: Article in Journal/Newspaper
• Language: English
• Published: Taylor & Francis 2017
• Subjects: Lungnakrabbamein; Brjóstholsskurðlækningar; Skurðlækningar; Lífslíkur; TAS12; PAD12; Pulmonary Surgical Procedures; Patient Outcome Assessment; Survival; Carcinoma; Non-Small-Cell Lung; Meier; TNM; Iceland
• Online Access: http://hdl.handle.net/2336/620219; https://doi.org/10.1080/0284186X.2017.1304652

Lobectomy is the standard curative treatment for non-small cell carcinoma (NSCLC) of the lung. Most studies on lobectomy have focused on short-term outcome and 30-day mortality. The aim of this study was to determine both short-term and long-term surgical outcome in all patients who underwent lobect...